Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03383848 · ClinicalTrials.gov registry record · NA
Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment
A NA study of Infertility, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
- 2
- Study locations
NCT03383848: Completed NA study of Infertility, sponsored by University of Michigan.
NCT03383848 is a NA study of Infertility that has completed, run by University of Michigan. The registered enrollment target is 164 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03383848, a NA study of Infertility, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate if an electronic medication management software solution can improve outcomes for patients undergoing in vitro fertilization (IVF) treatment. Participants will be randomized equally into two groups: half will use the management software, while the other half will act as a control group.
Primary Outcome
Common medication errors such as wrong dose, missed dose, or running out of medication, as captured through the software and/or reported by the patient to the clinical team caring for them during their IVF cycle.
Conditions Studied
Interventions
- DEVICE Medication Management Software
Study Locations (2)
Michigan
- Center for Reproductive Medicine, University of Michigan - Ann Arbor
- Northville Health Center - Northville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2020-10-31 |
| Phase | NA |
What the finished NCT03383848 record still lists
NCT03383848 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Medication Management Software is the first listed.
NCT03383848 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03383848 about?
NCT03383848 is a clinical study titled "Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment". This study will evaluate if an electronic medication management software solution can improve outcomes for patients undergoing in vitro fertilization (IVF) treatment. Participants will be randomized equally into two groups: half will use the management software, while the other half will act as a co...
What is the current status of trial NCT03383848?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2018-01-10. Estimated completion is 2020-10-31.
What conditions does trial NCT03383848 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT03383848?
The interventions under investigation include: Medication Management Software (DEVICE).
Who is sponsoring clinical trial NCT03383848?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03383848 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03383848's enrollment target sits among peer trials
164 45th of 74 higher than 30 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
RECRUITING · NA
-
Testicular Tissue Cryopreservation in Children
RECRUITING · NA
-
Sex Selection of Human Spermatozoa
RECRUITING · NA
-
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI